ESEYE LIMITED

1. Financial Health Score: B (Provisional)

Explanation: Based on the available corporate and compliance data, Eseye Limited presents as a mature, structurally sound patient. Having been incorporated in 2007, it has successfully navigated the volatile "infancy" phase that claims many tech startups. Its regulatory pulse is strong, with no overdue filings or signs of insolvency. However, this grade is provisional because the quantitative "blood test" results—such as turnover, net current assets, and profitability—are not present in the current dataset. The nominal share capital of £15 also suggests a complex financial anatomy that requires deeper examination to fully understand the equity structure.

2. Key Vital Signs

• Corporate Longevity (Age): 16+ Years. A very healthy sign. In the fast-paced tech and telecom sector, surviving past the 10-year mark indicates a resilient business model and an ability to adapt to market changes. This patient is well into mature adulthood.
• Regulatory Pulse (Filing Compliance): Strong & Regular. The company’s accounts are made up to a recent date (December 2024) and are not overdue. The confirmation statement is also up to date. This indicates excellent corporate hygiene and a lack of administrative distress.
• Organ Structure (Group Category & Officers): Complex but Robust. Operating as a "Group" suggests Eseye has subsidiary operations, which is common for global IoT providers. The board is diverse and well-staffed with five current directors of international composition (British, American, Canadian), which aligns perfectly with their global operational claims.
• Genetic Lineage (People with Significant Control): Opaque. The PSC register lists only a generic statement rather than naming individuals or firms. This means the ultimate beneficial owners are either a corporate entity, currently unknown, or protected from public view. While legal, it makes it harder to diagnose the full power structure and potential related-party risks.
• Capitalization (Share Capital): £15. This is a deceptively low number. In a medical sense, this is like checking a patient's wallet and finding only pennies, despite them appearing wealthy. It almost certainly means that the true financial value and equity are held in share premiums or reserves rather than issued share capital, which is common in venture-backed or privately funded tech firms.

3. Diagnosis

Eseye Limited presents as a mature, active enterprise in the wireless telecom and IT consultancy space. The absence of any liquidation flags, overdue filings, or director disqualifications tells us the patient is not in acute distress. The recent resignation of a director (Xxxxxx Xxxxxxxxname shown to subscribers) is a minor symptom, but entirely normal for a company of this size and age—akin to a minor staff changeover in a hospital ward.

The primary concern for a full diagnostic is the lack of visible quantitative financial metrics. Because the company falls into a filing category that may allow for abbreviated or group-exempt accounts, the public data lacks the "blood pressure and heart rate" readings (cash flow, net current assets, and retained profits). The £15 share capital is a structural anomaly that suggests the business relies heavily on premium reserves or external funding injections rather than traditional share capitalization.

4. Recommendations

To move from a provisional diagnosis to a clean bill of financial health, the following steps are recommended:

• Order the Full Blood Work: Obtain the full, unabbreviated filed accounts from Companies House for the last 3-5 years. You must review the Profit & Loss reserves, Net Current Assets (working capital), and Cash Flow statements to ensure the business is generating healthy cash flow rather than surviving on debt or continuous investor transfusions.
• Investigate the PSC Anomaly: Clarify the People with Significant Control. Understanding who ultimately owns and controls the company is vital for assessing financial stability. If a larger corporate entity owns Eseye, the parent's financial health will directly impact Eseye's prognosis.
• Review the Group Structure: Because Eseye is categorized as a "Group," request the consolidated financial statements if available. The health of the parent company is intrinsically tied to the health of its subsidiaries. Look for any symptoms of inter-company debt or cash trapping.
• Monitor the Board Transition: Keep an eye on the recent director resignation. While not currently a symptom of distress, sudden or multiple director departures can sometimes be an early warning sign of internal disagreements or financial strain.

Names of the people mentioned are shown to subscribers. See subscription